BioAge Labs (BIOA) Cash from Investing Activities (2024 - 2026)
BioAge Labs (BIOA) posted Cash from Investing Activities of -$46.8 million for Q1 2026, down 224.04% sequentially from -$14.4 million in Q4 2025, and up 40.05% YoY from -$33.4 million in Q1 2025.
BioAge Labs (BIOA) Cash from Investing Activities (2024 - 2026) Analysis & Trends
BioAge Labs has reported Cash from Investing Activities for 3 years, with the latest figure at -$46.8 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 40.05% year-over-year to -$46.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$64.0 million (up 18.34% YoY) and the FY2025 annual result came in at -$95.2 million, down 25915.3% from the prior year.
- Cash from Investing Activities slipped to -$46.8 million in Q1 2026 per BIOA's latest filing, from -$14.4 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $12.8 million in Q3 2025 and troughed at -$78.0 million in Q1 2025.
- A 3-year average of -$17.8 million and a median of -$7.4 million in 2024 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 4310.16% in 2025, down 55392.31% in 2025.
- Over 3 years, Cash from Investing Activities stood at -$26000.0 in 2024, then plunged by 55392.31% to -$14.4 million in 2025, then tumbled by 224.04% to -$46.8 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$46.8 million, -$14.4 million, and $12.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | -164.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -164.51 Mn |
| Jun 30, 2026 | -164.51 Mn |
| Mar 31, 2026 | -46.75 Mn |
| Mar 31, 2026 | -46.75 Mn |
| Dec 31, 2025 | -14.43 Mn |
| Dec 31, 2025 | -14.43 Mn |
| Sep 30, 2025 | 12.84 Mn |
| Sep 30, 2025 | 12.84 Mn |
| Jun 30, 2025 | -15.64 Mn |
| Jun 30, 2025 | -15.64 Mn |
| Mar 31, 2025 | -77.99 Mn |
| Mar 31, 2025 | -77.99 Mn |
| Dec 31, 2024 | -26,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Sep 30, 2024 | -305,000.00 |
| Sep 30, 2024 | -305,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -35,000.00 |